VOR vs FSCO
Comparison between Vor Biopharma Inc (VOR, Company) and FS Credit Opportunities Corp (FSCO, Company).
VOR is from the Healthcare sector, while FSCO is from the Financial Services sector.
VOR vs FSCO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
VOR vs FSCO - Historical Returns
Returns include dividend reinvestment.
VOR vs FSCO - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | VOR | FSCO |
|---|---|---|
| 2026 | +55.33% | -18.30% |
| 2025 | -41.61% | +4.79% |
| 2024 | -50.22% | +33.43% |
| 2023 | -66.72% | +38.45% |
| 2022 | -45.63% | +7.21% |
| 2021 | -69.01% | N/A |
VOR vs FSCO Drawdown Comparison
The maximum drawdown for VOR was -99.72%, occurring on May 9, 2025. This drawdown has not yet recovered.
The maximum drawdown for FSCO was -35.45%, occurring on Mar 9, 2026. This drawdown has not yet recovered.
The current VOR drawdown is -98.33%. The current FSCO drawdown is -28.06%.
| Rank | VOR | FSCO |
|---|---|---|
| #1 | -99.72% Feb 25, 2021 - May 9, 2025 | -35.45% Aug 28, 2025 - Mar 9, 2026 |
| #2 | -16.81% Feb 16, 2021 - Feb 24, 2021 | -25.09% Nov 18, 2022 - Aug 17, 2023 |
| #3 | -1.99% Feb 10, 2021 - Feb 12, 2021 | -17.89% Apr 1, 2025 - May 2, 2025 |
| #4 | N/A | -8.80% Jul 11, 2024 - Oct 2, 2024 |
| #5 | N/A | -6.48% Aug 25, 2023 - Sep 29, 2023 |
| #6 | N/A | -5.80% Nov 14, 2022 - Nov 17, 2022 |
| #7 | N/A | -5.13% Dec 27, 2023 - Feb 2, 2024 |
| #8 | N/A | -3.82% Nov 29, 2024 - Dec 20, 2024 |
| #9 | N/A | -3.65% Oct 11, 2023 - Nov 3, 2023 |
| #10 | N/A | -3.53% Mar 5, 2025 - Mar 20, 2025 |
| #11 | N/A | -3.48% Jan 22, 2025 - Feb 28, 2025 |
| #12 | N/A | -3.47% Feb 14, 2024 - Mar 15, 2024 |
| #13 | N/A | -3.40% Dec 1, 2023 - Dec 27, 2023 |
| #14 | N/A | -2.92% May 13, 2025 - May 29, 2025 |
| #15 | N/A | -2.90% Aug 4, 2025 - Aug 28, 2025 |
Correlation
Correlation between VOR and FSCO is -0.77 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks